Home › NDC Lookup › Ingredients › Calamine Plus Pramoxine Hcl › 83324-0242-41
Calamine Plus 5 mg/g; 10 mg/g; 79.5 mg/g Aerosol, Spray, 116 g — NDC 83324-0242-41 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Calamine Plus 5 mg/g; 10 mg/g; 79.5 mg/g Aerosol, Spray, 116 g — NDC 83324-242-41 (Billing 83324-0242-41)

by Chain Drug Marketing Association Inc · 116 g in 1 CANISTER

This is a package of 116 g of Calamine Plus 5 mg/g; 10 mg/g; 79.5 mg/g Aerosol, Spray from Chain Drug Marketing Association Inc, marketed since Jun 2024 and currently FDA-listed; retail pharmacies pay about $0.0434 per g (NADAC). It is this product's only package size.

NDC 83324-0242-41
🏷️ FDA NDC (as labeled) 83324-242-41 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 83324-242-41 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
83324 labeler · 242 product · 41 package
Package marketed since
Jun 7, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 8332424241 8
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83324-242-41
Product NDC 83324-242
11-digit billing NDC 83324024241
UNII 1K09F3G675, 88AYB867L5, SOI2LOH54Z
Application # M017
SPL Set ID 1a3f8819-58cf-8923-e063-6394a90a37af
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-06-07
Route TOPICAL
Dosage form AEROSOL, SPRAY
Substance FERRIC OXIDE RED; PRAMOXINE HYDROCHLORIDE; ZINC OXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 084632
GCN 53981
HICL code 010079
Ingredient (HICL) Pramoxine Hcl/Calamine
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L3
Therapeutic class — intermediate (HIC2) Protectives
HIC3 code L3P
Therapeutic class — specific (HIC3) Antipruritics,Topical
AHFS code 84:08.00.00
AHFS class Antipruritics And Local Anesthetics
FDB label name QC CALAMINE PLUS 8%-1% SPRAY
FDB brand name Calamine Plus
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 084632
  • GCN: 53981
  • HICL (First Databank): 010079
  • AHFS class code: 84:08.00.00
Why two NDCs? The FDA registers this code as 83324-242-41 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83324-0242-41. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name QC CALAMINE PLUS 8%-1% SPRAY Ingredient Pramoxine Hcl/Calamine
🧪 What is this product?

Calamine Plus is a topical aerosol spray containing three active ingredients commonly found in over-the-counter skin-relief products. Zinc oxide and ferric oxide red are typically used as mild protective and soothing agents for minor skin irritation. Pramoxine hydrochloride is a local anesthetic that functions to numb or reduce itching and discomfort on the skin. This product is marketed as an OTC monograph drug, meaning it follows FDA's established safety and use guidelines for this category of topical skin treatments.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.043 $5.03 / 116 g
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Dec 2025 Mar 2026 Jun 2026 Sep 2026 $0.044 $0.043
Flat over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83324-0242-41 You're viewing this Main listing 116 g in 1 CANISTER 2024-06-07 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Calamine Plus .345 mg/116g; 24.16 mg/116g; 2.72 mg/116g 46122-0745-31 AmerisourceBergen 116 g $0.043 — Availability likely —
Calamine Plus 5 mg/g; 10 mg/g; 79.5 mg/gthis 83324-0242-41 Chain 116 g $0.043 — Availability likely —
Calamine Plus Pramoxine HCl .345 mg/177mL; 24.16 mg/177mL; 2.72 mg/177mL 00363-8588-41 Walgreens 177 ml — — FDA listed —
Calamine Plus Pramoxine HCl .345 mg/116g; 24.16 mg/116g; 2.72 mg/116g 30142-0156-06 Kroger 116 g — — FDA listed —
Calamine Plus 79.6 mg/g; 10 mg/g; .4 mg/g 30142-0429-41 Kroger 116 g — — FDA listed —
Calamine Plus Pramoxine HCl .345 mg/116g; 24.16 mg/116g; 2.72 mg/116g 36800-0398-41 Topco 116 g — — FDA listed —
Calamine Plus Pramoxine HCL .345 mg/116g; 2.72 mg/116g; 24.16 mg/116g 41250-0235-41 Meijer 116 g — — Discontinued —
Calamine Plus Pramoxine HCl 5 mg/g; 75 mg/g; 10 mg/g 42507-0956-01 HY-VEE, 116 g — — FDA listed —
Calamine Plus .345 mg/mL; 2.72 mg/mL; 24.16 mg/mL 49035-0030-01 Wal-Mart 177 ml — — Discontinued —
Calamine Plus Pramoxine HCl 5 mg/g; 75 mg/g; 10 mg/g 56104-0100-10 Premier 116 g — — FDA listed —
Calamine Plus Pramoxine HCl .345 mg/116g; 24.16 mg/116g; 2.72 mg/116g 59779-0174-41 CVS 116 g — — FDA listed —
Calamine Plus Pramoxine HCl 5 mg/g; 75 mg/g; 10 mg/g 81522-0959-01 FSA 116 g — — FDA listed —
Calamine Plus Pramoxine HCl 5 mg/g; 75 mg/g; 10 mg/g 82442-0401-01 Target 116 g — — FDA listed —
Calamine Plus 5 mg/g; 10 mg/g; 79.5 mg/g 79481-0615-01 Meijer 116 g — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Jun 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII LKG8494WBH
    Benzyl alcohol is a clear liquid used as a preservative and solvent in medicines. It helps prevent bacterial and fungal growth and dissolves other ingredients to create uniform liquid formulations.
  • UNII 5TJD82A1ET
    A cooling crystalline substance made synthetically that is added to medicines as a fragrance, flavoring agent, and mild local irritant to produce a cooling or warming sensation on the skin or mucous membranes.
  • UNII X687XDK09L
    A clay mineral processed to carry positive charges, used as a thickener and suspending agent in liquid medicines. It helps keep solid particles evenly distributed throughout the product.
  • UNII Y6O7T4G8P9
    Hydrated silica is a fine powder form of silicon dioxide with absorbed water. It works as an anti-caking agent and absorbent in medicines, helping powders stay free-flowing and preventing clumping.
  • UNII BXR49TP611
    Isobutane is a liquefied gas used as a propellant in aerosol inhalers and sprays. It helps push the medicine out of the container so you can breathe or spray it as directed.
  • UNII 172F2WN8DV
    A fatty alcohol derived from animal or plant oils. It acts as an emollient and helps stabilize emulsions, allowing oil and water to mix evenly in the medication.
  • UNII QE6F49RPJ1
    A natural oil derived from sorbitol and oleic acid. It works as an emulsifier and solubilizer to help mix oil and water-based ingredients together and improve how the medicine dissolves or spreads in the body.

8 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesbenzyl alcohol, camphor, disteardimonium hectorite, fragrance, hydrated silica, isobutane, oleyl alcohol, SD alcohol 40-B, sorbitan trioleate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerChain Drug Marketing Association Inc
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code83324
First marketedJun 2024
Product typeHuman Otc Drug
Portfolio70 products on file

More NDCs from Chain Drug Marketing Association Inc labeler code 83324

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Keep Out of Reach of Children 📄 Other Information 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses temporarily relieves pain and itching associated with: insect bites rashes minor skin irritations minor cuts dries the oozing and weeping of poison ivy, poison oak and poison sumac

⏱️ Dosage and Administration 56 words ▾

Directions shake well before using adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily cleanse the skin with soap and water let dry before use children under 2 years of age: consult a doctor Other Information store between 20° to 25°C (68° to 77°F)

⚠️ Warnings 135 words ▾

Warnings For external use only. Flammable: Do not use while smoking or near heat or flame. Do not puncture or incinerate.

Contents under pressure. Do not store at temperatures above 120°F. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.

When using this product do not get into eyes ask a doctor before using on children under 2 years of age Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again in a few days Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Stop use and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again in a few days

🧪 Active Ingredient 7 words ▾

Active ingredients Calamine 8% Pramoxine HCI 1%

🧪 Inactive Ingredients 18 words ▾

Inactive ingredients benzyl alcohol, camphor, disteardimonium hectorite, fragrance, hydrated silica, isobutane, oleyl alcohol, SD alcohol 40-B, sorbitan trioleate

🎯 Purpose 5 words ▾

Purpose Skin protectant External analgesic

📄 When Using This Product 21 words ▾

When using this product do not get into eyes ask a doctor before using on children under 2 years of age

📄 Keep Out of Reach of Children 20 words ▾

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Other Information 10 words ▾

Other Information store between 20° to 25°C (68° to 77°F)

📄 Questions or Comments 3 words ▾

Questions? Call 1-866-964-0939

📄 Package Label / Principal Display Panel 50 words ▾

Principal Display Panel QC QUALITY CHOICE No-Rub NO-RUB Calamine Plus Spray Calamine 8% / Skin Protectant Pramoxine HCI 1% / External analgesic Relieves itching from poison ivy, oak & sumac, & insect bites Soothes minor skin irritations & cuts Shake well before use NET WT

4.1OZ. (116 g) label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 83324-0241-24 · Chain 83324-0245-06 · Chain →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.